Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–59.
Lamers F, van Oppen P, Comijs HC, Smit JH, Spinhoven P, van Balkom AJ, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2011;72:341–8.
Purves KL, Coleman JRI, Meier SM, Rayner C, Davis KAS, Cheesman R, et al. A major role for common genetic variation in anxiety disorders. Mol Psychiatry. 2020;25:3292–303.
Article CAS PubMed Google Scholar
Levey DF, Gelernter J, Polimanti R, Zhou H, Cheng Z, Aslan M, et al. Reproducible genetic risk loci for anxiety: results from ∼200,000 participants in the million veteran program. Am J Psychiatry. 2020;177:223–32.
Article PubMed PubMed Central Google Scholar
Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O’Shea DJ, et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature. 2011;477:171–8.
Article CAS PubMed PubMed Central Google Scholar
Duman RS, Sanacora G, Krystal JH. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron. 2019;102:75–90.
Article CAS PubMed PubMed Central Google Scholar
Terbeck S, Akkus F, Chesterman LP, Hasler G. The role of metabotropic glutamate receptor 5 in the pathogenesis of mood disorders and addiction: combining preclinical evidence with human positron emission tomography (PET) studies. Front Neurosci. 2015;9:86.
Article PubMed PubMed Central Google Scholar
Esterlis I, DellaGioia N, Pietrzak RH, Matuskey D, Nabulsi N, Abdallah CG, et al. Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [(11)C]ABP688 and PET imaging study in depression. Mol Psychiatry. 2018;23:824–32.
Article CAS PubMed Google Scholar
Wierońska JM, Pilc A. Depression and schizophrenia viewed from the perspective of amino acidergic neurotransmission: antipodes of psychiatric disorders. Pharmacol Ther. 2019;193:75–82.
Lüscher C, Huber KM. Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron. 2010;65:445–59.
Article PubMed PubMed Central Google Scholar
Senter RK, Ghoshal A, Walker AG, Xiang Z, Niswender CM, Conn PJ. The role of mGlu receptors in hippocampal plasticity deficits in neurological and psychiatric disorders: implications for allosteric modulators as novel therapeutic strategies. Curr Neuropharmacol. 2016;14:455–73.
Article CAS PubMed PubMed Central Google Scholar
Doherty AJ, Palmer MJ, Henley JM, Collingridge GL, Jane DE. (RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but not mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology. 1997;36:265–7.
Article CAS PubMed Google Scholar
Homayoun H, Stefani MR, Adams BW, Tamagan GD, Moghaddam B. Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release. Neuropsychopharmacology. 2004;29:1259–69.
Article CAS PubMed Google Scholar
Niswender CM, Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol. 2010;50:295–322.
Article CAS PubMed PubMed Central Google Scholar
Shigemoto R, Nomura S, Ohishi H, Sugihara H, Nakanishi S, Mizuno N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett. 1993;163:53–57.
Article CAS PubMed Google Scholar
Romano C, Sesma MA, McDonald CT, O’Malley K, Van den Pol AN, Olney JW. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol. 1995;355:455–69.
Article CAS PubMed Google Scholar
Kim SE, Joo Y-H, Son Y-D, Kim H-K, Lee S-Y, Lee M-W, et al. Association between human gray matter metabotropic glutamate receptor-5 availability in vivo and white matter properties: a [11C]ABP688 PET and diffusion tensor imaging study. Brain Struct Funct. 2020;225:1805–16.
Article CAS PubMed Google Scholar
Kerner JA, Standaert DG, Penney JB, Young AB, Landwehrmeyer GB. Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus. Mol Brain Res. 1997;48:259–69.
Article CAS PubMed Google Scholar
van Hooft JA, Giuffrida R, Blatow M, Monyer H. Differential expression of group I metabotropic glutamate receptors in functionally distinct hippocampal interneurons. J Neurosci. 2000;20:3544–51.
Article PubMed PubMed Central Google Scholar
Sun QQ, Zhang Z, Jiao Y, Zhang C, Szabó G, Erdelyi F. Differential metabotropic glutamate receptor expression and modulation in two neocortical inhibitory networks. J Neurophysiol. 2009;101:2679–92.
Article CAS PubMed PubMed Central Google Scholar
Lee J, Munguba H, Gutzeit VA, Singh DR, Kristt M, Dittman JS, et al. Defining the homo- and heterodimerization propensities of metabotropic glutamate receptors. Cell Rep. 2020;31:107605.
Article CAS PubMed PubMed Central Google Scholar
Jew CP, Wu CS, Sun H, Zhu J, Huang JY, Yu D, et al. mGluR5 ablation in cortical glutamatergic neurons increases novelty-induced locomotion. PLoS One. 2013;8:e70415.
Article CAS PubMed PubMed Central Google Scholar
Wu CS, Jew CP, Sun H, Ballester Rosado CJ, Lu HC. mGlu5 in GABAergic neurons modulates spontaneous and psychostimulant-induced locomotor activity. Psychopharmacology (Berl). 2020;237:345–61.
Article CAS PubMed Google Scholar
Lee KW, Westin L, Kim J, Chang JC, Oh YS, Amreen B, et al. Alteration by p11 of mGluR5 localization regulates depression-like behaviors. Mol Psychiatry. 2015;20:1546–56.
Article CAS PubMed PubMed Central Google Scholar
Barnes SA, Pinto-Duarte A, Kappe A, Zembrzycki A, Metzler A, Mukamel EA, et al. Disruption of mGluR5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders. Mol Psychiatry. 2015;20:1161–72.
Article CAS PubMed PubMed Central Google Scholar
Liguz-Lecznar M, Dobrzanski G, Kossut M. Somatostatin and somatostatin-containing interneurons-from plasticity to pathology. Biomolecules. 2022;12:312.
Article CAS PubMed PubMed Central Google Scholar
Cummings KA, Clem RL. Prefrontal somatostatin interneurons encode fear memory. Nat Neurosci. 2020;23:61–74.
Article CAS PubMed Google Scholar
Keum S, Kim A, Shin JJ, Kim JH, Park J, Shin HS. A missense variant at the Nrxn3 locus enhances empathy fear in the mouse. Neuron. 2018;98:588–601.e585.
Article CAS PubMed Google Scholar
Besnard A, Gao Y, TaeWoo Kim M, Twarkowski H, Reed AK, Langberg T, et al. Dorsolateral septum somatostatin interneurons gate mobility to calibrate context-specific behavioral fear responses. Nat Neurosci. 2019;22:436–46.
Article CAS PubMed PubMed Central Google Scholar
Lovett-Barron M, Kaifosh P, Kheirbek MA, Danielson N, Zaremba JD, Reardon TR, et al. Dendritic inhibition in the hippocampus supports fear learning. Science. 2014;343:857–63.
Article CAS PubMed PubMed Central Google Scholar
Yu K, Garcia da Silva P, Albeanu DF, Li B. Central amygdala somatostatin neurons gate passive and active defensive behaviors. J Neurosci. 2016;36:6488–96.
Article CAS PubMed PubMed Central Google Scholar
Liguz-Lecznar M, Urban-Ciecko J, Kossut M. Somatostatin and somatostatin-containing neurons in shaping neuronal activity and plasticity. Front Neural Circuits. 2016;10:48.
Article PubMed PubMed Central Google Scholar
Wang Y, Toledo-Rodriguez M, Gupta A, Wu C, Silberberg G, Luo J, et al. Anatomical, physiological and molecular properties of Martinotti cells in the somatosensory cortex of the juvenile rat. J Physiol. 2004;561:65–90.
Article CAS PubMed PubMed Central Google Scholar
Ma Y, Hu H, Berrebi AS, Mathers PH, Agmon A. Distinct subtypes of somatostatin-containing neocortical interneurons revealed in transgenic mice. J Neurosci. 2006;26:5069–82.
留言 (0)